CVRdatabase
Menu

VIPpharma ApS

Private limited companyCVR 38744763KarlslundeActive

VIPpharma ApS is a private limited company, based in Karlslunde, active in public relations and communication activities, founded in 2017. Net profit fell 43% from 2024 to 2025, ending at DKK 675k. Equity fell to DKK 1.3m in 2025.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profitDKK 2.4m−22.5% vs. 2024
Net profitDKK 675k−43.4% vs. 2024
EquityDKK 1.3m−31.3% vs. 2024
Employees3latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Gross profit fell 23% (2024 → 2025), to DKK 2.4m.
  • Net profit fell 43% (2024 → 2025), to DKK 675k.
  • Equity fell 31% (2024 → 2025), to DKK 1.3m.

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

DKK 0DKK 500kDKK 1mDKK 1.5mDKK 2mDKK 2.5mDKK 3mDKK 3.5m202020212022202320242025
EquityNet profit
Financial figures for VIPpharma ApS
202020212022202320242025Change
Revenuenot statednot statednot statednot statednot statednot stated–
Gross profit2,1512,0762,3572,5853,1392,432−22.5%
Profit before tax8845588259781,564884−43.5%
Net profit7164286347431,191675−43.4%
Total assets4,4263,1072,9132,9292,7802,303−17.2%
Equity3,6922,3702,0041,7471,8391,263−31.3%
Liabilities–––––1,039–
Cash and cash equivalents1,686508456722364385+5.7%
Average number of employees2222220%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

DKK 0DKK 500kDKK 1mDKK 1.5mDKK 2mDKK 2.5mDKK 3m202020212022202320242025
Gross profitMedian, the industry (195 companies)

Signals from the financial statements

calculated from the 2025 figures

  • Equity fell sharply

    Equity fell 31% from 2024 to 2025 (DKK 1.8m to DKK 1.3m).

    How is this calculated?

    Equity has fallen by at least 30% from the previous annual report, and it was positive the year before.

  • Profit for five years in a row

    Net result has been positive in 2021–2025.

    How is this calculated?

    Net result is positive in the five latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for VIPpharma ApS
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202503/06/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202413/06/2025The companyPDFXBRL
202301/01/2023 – 31/12/202302/05/2024The companyPDFXBRL
202201/01/2022 – 31/12/202218/06/2023The companyPDFXBRL
202101/01/2021 – 31/12/202127/06/2022The companyPDFXBRL
202001/01/2020 – 31/12/202009/07/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
011223308/2309/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/26
Employees

Position in the industry

195 companies in the database

Comparison with the other companies in public relations and communication activities based on the latest financial year.

Gross profitDKK 2.4mNo. 75 of 195
Better than 62% of the companies in the industry
EquityDKK 1.3mNo. 63 of 195
Better than 68% of the companies in the industry
Number of employees3No. 100 of 195
Better than 49% of the companies in the industry

Industry median: gross profit DKK 1.7m, net profit DKK 141k, equity DKK 635k, 3 employees.

DKK 100kDKK 499kDKK 2.5mDKK 12.4mDKK 36.3mHere
Distribution of gross profit for 184 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 26,874of 69,742
Better than 61%
No. 30,525of 69,964
Better than 56%
Same industry and fewer than 20 employees176 companies in the comparison
No. 58of 176
Better than 67%
No. 48of 176
Better than 73%
Companies that are between 5 and 14 years old33,688 companies in the comparison
No. 15,058of 33,588
Better than 55%
No. 13,869of 33,687
Better than 59%
All companies of type ApS66,508 companies in the comparison
No. 26,258of 66,379
Better than 60%
No. 26,460of 66,505
Better than 60%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Public relations and communication activities
Gross profit
  1. VIPpharma ApSDKK 2.4m
  2. Rud Pedersen A/SDKK 62m
  3. Geelmuyden.kiese A/SDKK 58.6m
Net profit
  1. VIPpharma ApSDKK 675k
  2. Rud Pedersen A/SDKK 8.2m
  3. Geelmuyden.kiese A/SDKK 11.6m
Equity
  1. VIPpharma ApSDKK 1.3m
  2. Rud Pedersen A/SDKK 15.5m
  3. Geelmuyden.kiese A/SDKK 17m
Employees
  1. VIPpharma ApS3
  2. Rud Pedersen A/S64
  3. Geelmuyden.kiese A/S58

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • VIPinvest ApS100%
VIPpharma ApS

Management

1 active registrations

Executive management

Executive management at VIPpharma ApS
NameRoleAppointed
Vibeke WærensDirector24/06/2017
Founders
Vibeke Wærens

Signing rule: Virksomheden tegnes  af direktionen

Address and production units

1 active production units

Bjælkevangen 9
2690 Karlslunde

Greve Municipality · Postcode 2690

Other companies at the address (1)

Production units
Production unitAddressEmployeesP number
VIPpharma ApSBjælkevangen 9, 2690 Karlslunde31022577677

Purpose

Virksomhedens formål er at drive public relations og kommunikation eller anden efter direktionens skøn hermed beslægtet virksomhed.

The purpose is quoted from the register in Danish.

Changes year by year

12 registered events
20261 changeaccounts 1
  • Annual report for 2025 published
20251 changeaccounts 1
  • Annual report for 2024 published
20241 changeaccounts 1
  • Annual report for 2023 published
20231 changeaccounts 1
  • Annual report for 2022 published
20221 changeaccounts 1
  • Annual report for 2021 published
20211 changeaccounts 1
  • Annual report for 2020 published
20202 changesownership 2
  • VIPinvest ApS registered as owner (100%)
  • Vibeke Wærens is no longer registered as owner
20181 changeaddress 1
  • Moved to Bjælkevangen 9, 2690 Karlslunde
20173 changesfounded 1 · management 1 · ownership 1
  • Registered as VIPpharma ApS
  • Vibeke Wærens appointed director
  • Vibeke Wærens registered as owner (100%)

Related companies

Same industry in Greve

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction